1. Home
  2. NOTV vs RECT Comparison

NOTV vs RECT Comparison

Compare NOTV & RECT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • RECT
  • Stock Information
  • Founded
  • NOTV 1974
  • RECT 1997
  • Country
  • NOTV United States
  • RECT Singapore
  • Employees
  • NOTV N/A
  • RECT N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • RECT
  • Sector
  • NOTV Health Care
  • RECT
  • Exchange
  • NOTV Nasdaq
  • RECT Nasdaq
  • Market Cap
  • NOTV 57.7M
  • RECT 66.1M
  • IPO Year
  • NOTV 1997
  • RECT 2024
  • Fundamental
  • Price
  • NOTV $1.69
  • RECT $4.51
  • Analyst Decision
  • NOTV Strong Buy
  • RECT
  • Analyst Count
  • NOTV 1
  • RECT 0
  • Target Price
  • NOTV $5.00
  • RECT N/A
  • AVG Volume (30 Days)
  • NOTV 429.6K
  • RECT 2.4K
  • Earning Date
  • NOTV 08-06-2025
  • RECT 07-31-2025
  • Dividend Yield
  • NOTV N/A
  • RECT N/A
  • EPS Growth
  • NOTV N/A
  • RECT N/A
  • EPS
  • NOTV N/A
  • RECT 0.12
  • Revenue
  • NOTV $505,299,000.00
  • RECT $32,594,177.00
  • Revenue This Year
  • NOTV $5.64
  • RECT N/A
  • Revenue Next Year
  • NOTV $5.16
  • RECT N/A
  • P/E Ratio
  • NOTV N/A
  • RECT $38.06
  • Revenue Growth
  • NOTV 0.85
  • RECT 5.91
  • 52 Week Low
  • NOTV $1.15
  • RECT $2.78
  • 52 Week High
  • NOTV $6.48
  • RECT $7.68
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 41.79
  • RECT 41.34
  • Support Level
  • NOTV $1.65
  • RECT $4.31
  • Resistance Level
  • NOTV $1.85
  • RECT $4.72
  • Average True Range (ATR)
  • NOTV 0.13
  • RECT 0.14
  • MACD
  • NOTV -0.01
  • RECT -0.01
  • Stochastic Oscillator
  • NOTV 8.33
  • RECT 41.67

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About RECT Rectitude Holdings Ltd Ordinary Shares

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks.

Share on Social Networks: